Ind-Swift Laboratories Limited (BOM:532305)
India · Delayed Price · Currency is INR 329.35
-3.90 (-1.17%)
At close: Aug 21, 2026
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 28.66 billion as of August 21, 2026. Its market cap has increased by 289.79% in one year.
Market Cap
28.66B
Enterprise Value
24.45B
Revenue
6.74B
Ranking
n/a
PE Ratio
50.00
Stock Price
329.35
ChartMarket Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 28.66B, an increase of 25,602.31%. That is a compound annual growth rate of 22.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 28.66B | 298.41% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 298.90B |
| Shilpa Medicare | 157.89B |
| Suven Life Sciences | 87.63B |
| IOL Chemicals and Pharmaceuticals | 46.08B |
| Gujarat Themis Biosyn | 39.98B |
| Sai Parenteral's | 23.87B |
| NGL Fine-Chem | 18.82B |
| Bajaj HealthCare | 10.75B |